Cargando…
The use of prostate MR for targeting prostate biopsies
Management of prostate cancer relies heavily on accurate risk stratification obtained through biopsies, which are conventionally performed under transrectal ultrasound (TRUS) guidance. Yet, multiparametric MRI has grown to become an integral part of the care of males with known or suspected prostate...
Autores principales: | Kelley, R. Phelps, Zagoria, Ronald J., Nguyen, Hao G., Shinohara, Katsuto, Westphalen, Antonio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592478/ https://www.ncbi.nlm.nih.gov/pubmed/33178929 http://dx.doi.org/10.1259/bjro.20180044 |
Ejemplares similares
-
US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy
por: Velarde, Nathan, et al.
Publicado: (2022) -
Differences in negative predictive value of prostate MRI based in men
with suspected or known cancer
por: Baghdanian, Armonde A., et al.
Publicado: (2019) -
A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study
por: Balakrishnan, Ashwin S, et al.
Publicado: (2019) -
Detection of clinically significant prostate cancer with PI-RADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions
por: Westphalen, Antonio C., et al.
Publicado: (2019) -
Impact of the integration of proton magnetic resonance imaging
spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate
cancer
por: Leapman, Michael S., et al.
Publicado: (2017)